<DOC>
	<DOC>NCT00355810</DOC>
	<brief_summary>This randomised, double blind, cross-over study compares the effect (symptoms, fecal bacterial growth, gas production) of three weeks' treatment with lactobacillus plantarum MF 1298 with placebo in patients with irritable bowel syndrome. The results are related to dietary habits, food intolerance and food allergy.</brief_summary>
	<brief_title>Probiotics for Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<criteria>Irritable bowel syndrome according to the Rome II criteria regular symptoms Use of probiotics last three weeks pregnancy lactation coexisting other gastrointestinal disorders use of laxatives and antibiotics within last 5 weeks.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Probiotics</keyword>
</DOC>